Cellegy Contraception Gel Study Continues After Firm Drops HIV Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase III Nigerian trial was halted after data monitoring committee determines the microbicide was unlikely to show convincing evidence it protects against HIV.